2-DG, a new indigenous anti-COVID drug to boost fight against COVID-19 |
Editorial
eMediNexus Coverage from: 
2-DG, a new indigenous anti-COVID drug to boost fight against COVID-19

10 Read Comments                

2-deoxy-D-glucose (2-DG), an indigenously developed anti-COVID drug was officially launched yesterday by the Defence Minister Rajnath Singh and the Union Health Minister Dr Harsh Vardhan. The first batch comprising of more than 10,000 doses of the drug was released.2-DG has been developed by Defence Research and Development Organisation (DRDO)’s Institute of Nuclear Medicine and Allied Sciences (INMAS) and Dr Reddy’s Laboratories (DRL), Hyderabad.The drug has gone through the three phases of clinical trials. Published data for the trials is not yet available; however, as per the Ministry of Defence press release dated 8th May, 2021, “Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID pa...
To Read or comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now